|
Share your experience in this quick 5-minute survey on bone health in patients with metastatic prostate cancer receiving androgen deprivation therapy.
Developed by the European Association of Urology Young Academic Urologists (YAU) Prostate Cancer Working Group, this survey aims to better understand global clinical practice, including the use of bone-protecting agents, bone mineral density assessment, and barriers to guideline implementation.
Open to medical oncologists, radiation oncologists, and urologists involved in patient care.
|
